To effectively control the spread of the SARS-CoV-2, accurate detection of infectious cases is critical. The COVID-19 MDx RT-PCR is intended for qualitative detection of SARS-CoV-2 RNA in upper respiratory specimens (such as and nasopharyngeal wash/aspirate or nasal aspirate) and bronchoalveolar lavage from individuals suspected of COVID-19 by their healthcare provider. At this time, testing is limited to CLIA-certified laboratories.
  • Designed for use on those displaying symptoms of COVID-19
    Administered via nasopharyngeal, oropharyngeal and nasal swabs and nasopharyngeal wash/aspirate or nasal aspirate, and bronchoalveolar lavage.
    To detect all of SARS-CoV-2 mutations amplifies two unique target qenes of SARS-CoV-2
    Processing time is less than 83 minutes

    Clinically validated with high sensitivity and specificity
    Available for use with the following lab systems:

    1. CFX96™ system (Bio-Rad Laboratories, Inc.)
    2. Applied Biosystems 7500/7500 Fast Real-Time PCR System
      (Thermofisher Scientific)
  • Product specifications

    Package unit: 100 Tests / Kit
    Technology: Real-time transcription PCR
    Reaction time: 83 minutes
    Performance:
    Analyte: 2019-NOVEL CORONAVIRUS (SARS-COV-2)
    Specimen type: Upper respiratory specimens including nasopharyngeal, oropharyngeal and nasal swabs and nasopharyngeal wash / aspirate or nasal aspirate, and bronchoalveolar lavage
    Sample volume: 10 ml RNA
    Storage: Below -20°C
    Shelf-life: 12 months
    Internal control: MS2 PHAGE control
    External control: Positive control, negative control
    Kit component:
    4 x 1 step RT-PCR mix, SARS-COV-2 primer/probe mix, MS2-PHAGE controls positive control, negative control IFU

  • Order Information

    Cat. No.: MCGM-100072
    Package unit: 100 Tests / Kit
    Kit component:
    4 x 1 step RT-PCR mix 2019-NCOV primer/probe MS2-PHAGE control positive control negative control IFU

  • Test method